What Is CytoMed Therapeutics Limited (GDTC) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, CytoMed Therapeutics Limited's intrinsic value is estimated at $0.47. Trading at its current price of $1.02, the valuation engine raises significant caution: 8 of 9 models flag downside risk, projecting an average implied return of -53.6%. Model dispersion is worth noting: PWERM targets $1.08 (+5.6%), versus ML-RIV at $0.05 (-94.6%). This +100.2% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About GDTC?
9 of 13 models are currently active for GDTC. Of these, 1 model suggests upside while 8 models suggest overvaluation. The Bayesian DCF estimates GDTC's intrinsic value at $0.47, implying -54.3% downside from the current price. See which stocks rank higher →
How Does GDTC Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, GDTC ranks #204 by Quality of Company score. CirclFi's QOC score of 5.0/10 evaluates 32 fundamental signals. A score of 5.0 reflects mixed fundamentals.
See all Most Undervalued Pharmaceutical Preparations Stocks →
CytoMed Therapeutics Limited's positioning within the Pharmaceutical Preparations segment means that revenue per drug plays an outsized role in fundamental analysis. The sector's unique characteristics — including orphan drug designation — shape both the opportunity set and risk profile.
Is GDTC a Value Trap?
CirclFi's Value Trap algorithm assigns GDTC a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
9 of 13 models are active for CytoMed Therapeutics Limited. Moderate coverage provides meaningful perspective. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, CytoMed Therapeutics Limited earns a quality score of 5.0/10. This mixed rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +100.2% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every GDTC valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across GDTC's 9 active models, average confidence is 20%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad